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SUMMARY
The ability of hematopoietic stem cells (HSCs) to
self-renew is a prerequisite for the establishment of
definitive hematopoiesis and life-long blood regener-
ation. Here, we report the single-stranded DNA-bind-
ing transcriptional regulator far upstream element
(FUSE)-binding protein 1 (FUBP1) as an essential
factor of HSC self-renewal. Functional inactivation
of FUBP1 in two different mouse models resulted in
embryonic lethal anemia at around E15.5 caused by
severely diminished HSCs. Fetal and adult HSCs
lacking FUBP1 revealed an HSC-intrinsic defect in
their maintenance, expansion, and long-term blood
reconstitution, but could differentiate into all hemato-
poietic lineages. FUBP1-deficient adult HSCs exhibit
significant transcriptional changes, including upre-
gulation of the cell-cycle inhibitor p21 and the pro-
apoptotic Noxamolecule. These changes caused an
increase in generation time and death of HSCs as
determined by video-microscopy-based tracking.
Our data establish FUBP1 and its recognition of sin-
gle-stranded genomic DNA as an important element
in the transcriptional regulation of HSC self-renewal.
INTRODUCTION
Long-term repopulating hematopoietic stem cells (LT-HSCs)
give rise to the lifelong regeneration of all mature blood cell lin-
eages. They are at the apex of the hematopoietic differentiation
hierarchy consisting of several progenitor cell stages with
restricted stemness and lineage potential (Orkin and Zon,
2008; Rieger and Schroeder, 2012). During embryonic develop-
ment, definitive LT-HSCs colonize the fetal liver (FL) and
expand extensively by undergoing rapid self-renewal divisions
to establish the pool of LT-HSCs required for adult life. In
contrast, adult LT-HSCs primarily reside in a quiescent G0
cell-cycle phase, rarely divide, and are maintained at constant
cell numbers (Pietras et al., 2011; Qiu et al., 2014; Wilson et al.,
2008) to ensure lifelong blood regeneration. LT-HSC self-
renewal is significantly increased only during hematopoietic
stress conditions, such as infections, anemia, or bone marrow
(BM) cell depletion, e.g., upon chemotherapeutic treatment
(Wilson et al., 2008).
Although transcription factors essential for the establishment
of definitive LT-HSCs in fetal tissues have been identified, such
as RUNX1 (Samokhvalov et al., 2007) and TAL1 (Mikkola et al.,
2003; Schlaeger et al., 2005), the transcriptional network that
governs the self-renewal and expansion programs in LT-HSCs
remains poorly understood. Furthermore, identification of the
essential components of the self-renewal program is key to
achieving a robust expansion of LT-HSCs ex vivo (Nishino
et al., 2012; Wohrer et al., 2014).
We have previously identified FUBP1 as an anti-apoptotic
and pro-proliferative oncoprotein that is overexpressed in he-
patocellular carcinomas (HCCs) (Malz et al., 2009; Rabenhorst
et al., 2009). FUBP1 functions as a transcriptional regulator by
binding to the single-stranded DNA element FUSE and interact-
ing with the basal transcriptional machinery (Chung and Lev-
ens, 2005). Target genes regulated by FUBP1 include the
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immediate early gene c-myc (Duncan et al., 1994), the cell-cy-
cle inhibitor p21 (Rabenhorst et al., 2009), and the deubiquiti-
nating enzyme Usp29 (Liu et al., 2011). To study the physiolog-
ical function of FUBP1 in vivo, we generated gene trap mouse
models lacking FUBP1 activity. The homozygous Fubp1null/null
gene trap embryos die in utero at approximately day E15.5
with a severe anemic phenotype, thereby indicating that
FUBP1 plays a role in hematopoietic development and/or
homeostasis.
Our analyses demonstrate that FUBP1 is specifically required
for LT-HSC self-renewal and survival during fetal and adult
hematopoiesis, while its absence does not prevent the genera-
tion of all hematopoietic cell lineages. The operating mode of
FUBP1 suggests that the presence of single-stranded genomic
DNA structures represents an additional level of self-renewal
regulation.
RESULTS AND DISCUSSION
FUBP1 Inactivation Results in Embryonic Lethality and
Loss of LT-HSCs
Motivated by our previous studies on the oncogenic function of
FUBP1, we generated two independent gene trap mouse lines
(GT 1 and GT 2) that lack WT FUBP1 protein (Figure 1B; for
further details, see Experimental Procedures). Both strains ex-
hibited a similar phenotype. Accordingly, all homozygous mice
derived from heterozygous matings died at approximately day
E15.5 and were severely anemic (Figure 1A). The total FL cell
numbers in E15.5 Fubp1null/null embryos were markedly reduced
(Figure 1C). However, the proportion and subtype distribution of
the colony-forming progenitor cells (CFU-GM, CFU-GEMM, and
CFU-MK-E) were similar in the WT and FUBP1-deficient FLs
(Figure 1D). When we analyzed the hematopoietic stem and pro-
genitor cell (HSPC) populations by their well-established surface
marker profile (Figures 1E and 1F; Table S1) (Kim et al., 2006), we
found that fetal LT-HSCs (CD150+ CD48 Mac-1+ KSL) were
severely reduced in proportion and number in the FUBP1-defi-
cient FLs (Figure 1F, left). In contrast, the numbers of CD150
CD48+ MPPs and Mac-1+ KSL (immature compartment; Morri-
son et al., 1995) cells remained largely unaffected by the
absence of FUBP1 (Figure 1F, middle and right). To test whether
the anemia observed in homozygous mutant Fubp1null/null em-
bryos is mainly caused by the loss of definitive LT-HSCs, we
analyzed the different erythroid progenitors and myelocytes in
peripheral blood (PB) and FL of WT and FUBP1-deficient em-
bryos at E11.5, when the majority of red blood cells still originate
from the HSC-independent primitive lineages. Our data showed
that erythropoiesis and myelopoiesis at this early stage appear
unaffected by the absence of FUBP1 (Figures S1A and S1B).
The analysis of colony-forming cells (Figure 1D), MPPs, and
Mac-1+ KSL cells (Figure 1F) indicated that FUBP1, while essen-
tial for the maintenance of LT-HSCs, might be dispensable for
the differentiation of the different hematopoietic lineages. To
confirm this conclusion, we analyzed the proportion of hemato-
poietic lineages in the FL of E15.5 embryos. As shown in Fig-
ure S1C, the myelomonocytic, erythroid, and lymphocytic line-
ages (B and T cells) are present in equal proportions in WT and
Fubp1null/null FL.
We then prospectively isolated MEPs, GMPs, LMPPs, and
MPP2s from E15.5 FL (gating strategy shown in Figure S2A)
and evaluated their colony-formation potential. Equal numbers
and comparable types of colonies with similar size were gener-
ated from all WT and Fubp1null/null progenitor cell populations
(Figures S2B and S2C), supporting the notion that all hematopoi-
etic lineages are generated in the absence of FUBP1.
Fetal LT-HSCs Require FUBP1 for Self-Renewal and
Long-Term Repopulation
To functionally validate the cell surface marker-based analyses
that indicated lack of Fubp1null/null LT-HSCs in FLs at E15.5,
we competitively transplanted 5 3 104 lin WT or Fubp1null/null
(GT 1) FL cells into lethally irradiated recipient mice (Figure 2A)
and monitored donor cell repopulation in the PB. Consistent
with the anemic phenotype of FUBP1-deficient embryos,
Fubp1null/null FL cell engraftment was significantly reduced
when compared with the WT FL cell engraftment (Figure 2B).
Importantly, no major differences in the contribution of B, T,
and myeloid cells from WT or Fubp1null/null donor cells were
observed (Figure 2C), further supporting the notion that FUBP1
is dispensable for multilineage differentiation.
Then, we investigated the HSPC composition in primary recip-
ient BM at 11 and 21 weeks to evaluate whether the reduced pri-
mary engraftment was due to a reduction or complete depletion
of the HSC population. While the proportion of donor-derived
MPPs was similar between recipients receiving Fubp1null/null or
WT cells, the percentage of FUBP1-deficient LT-HSCs had
already decreased 11 weeks after transplantation (Figures 2D
and 2E), and virtually no Fubp1null/null LT-HSCs were detected
after 21 weeks (original flow cytometry plots and gating strate-
gies for the BM analyses are displayed in Figure S3).
To validate the absence of phenotypic FUBP1-deficient
LT-HSCs after 21 weeks in primary recipient BM, displaying
inability to self-renew, we serially transplanted 1 3 104 WT or
Fubp1null/null CD45.2+ lin c-Kit+ BM cells (BMCs) competitively
into lethally irradiated recipient mice (Figure 2A). Flow cytometry
analysis of PB and BM revealed no engraftment of Fubp1null/null
donor cells due to the complete absence of LT-HSCs (Figures
2F and 2G), whereas WT donor cells long-term engrafted. The
transplantation data clearly confirmed the low number of defini-
tive LT-HSCs in Fubp1null/null FLs at E15.5 with impaired self-
renewal capacity.
Collectively, our results demonstrate that functional FUBP1 is
required for definitive LT-HSC self-renewal, expansion, and
long-term repopulation capacity in the FL.
FUBP1 Is Essential for Adult HSC Self-Renewal
Given that we observed that FUBP1-deficient mice lack pheno-
typic and functional LT-HSCs in the FL, we hypothesized that LT-
HSCs intrinsically require FUBP1 for self-renewal and expansion
during definitive hematopoiesis. To verify this hypothesis and
assess the functional consequences of FUBP1 deficiency on
LT-HSC fate decisions, we knocked down Fubp1 in adult murine
LT-HSCs using two different lentiviral shRNA constructs. Next,
we competitively transplanted adult LT-HSCs that were lentivir-
ally transduced with shRNAs against Fubp1 or a scrambled con-
trol into lethally irradiated recipient mice (Figure 3A). Expression
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of both Fubp1 shRNAs led to a significant reduction in the
amount of FUBP1 protein. Of note, shRNA #2 was more efficient
in reducing FUBP1 levels (Figure 3B). Knockdown of Fubp1 in
LT-HSCs drastically reduced blood cell reconstitution in the
PB and BM over time (Figures 3C and 3E). However, similar
to the FUBP1-deficient FL cells, the knockdown of Fubp1 in
LT-HSCs did not prevent the generation of all hematopoietic
lineages (Figure 3D).
Figure 1. Loss of Murine FUBP1 Activity Resulted in Embryonic Lethality and a Reduction in LT-HSCs
(A) Fubp1null/null embryos of both gene trap (GT) models displayed a severe anemic phenotype and died at approximately day E15.5.
(B) Western blot analysis demonstrated the complete loss of WT FUBP1 protein expression in homozygous Fubp1null/null gene trap mice. Protein lysates were
isolated from E13.5 MEFs (GT 1) and E15.5 embryos (GT 2).
(C) FL total cell number (+/+: n = 18 [GT 1], n = 17 [GT 2], null/null: n = 12 [GT 1], n = 12 [GT 2]; seven and four independent experiments for GT 1 and GT 2,
respectively; unpaired t test).
(D) Colony-formation potential of GT 1 E15.5 FL cells (+/+: n = 5, null/null: n = 5; two independent experiments).
(E and F) HSPCs in Fubp1null/null and WT E15.5 FLs determined via flow cytometry. (E) Representative flow cytometry plots. (F) Relative and absolute flow cy-
tometric quantification (WT: n = 6 [GT 1], n = 6 [GT 2], null/null: n = 5 [GT 1], n = 8 [GT 2]; two independent experiments). Test for statistical significance: unpaired
Student’s t test. Data are represented as the mean and SD.
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To establish whether adult LT-HSCs require FUBP1 for self-
renewal, we performed secondary transplantations of equal
numbers of transduced (CD45.2+ Venus+) cells isolated from
the BM 8 weeks after the primary transplant (Figure 3A). The
PB analysis from week 2 to week 18 post-secondary transplan-
tation (Figure 3F) and the terminal analysis of the BM at 20 weeks
(Figure 3H) showed markedly reduced blood cell reconstitution
of the Fubp1 knockdown donor cells compared with the control
donor cells (scrambled shRNA). From week 14 on after trans-
plantation, Fubp1 knockdown donor cells contributed less than
1% to the total number of CD45+ cells in PB, while scrambled
control shRNA-transduced donor cells remained stable above
1% contribution (Figure 3F). In the BM, the difference is even
more obvious, with more than 10% of scrambled control donor
cells contributing to the total number of CD45+ cells, while
FUBP1-deficient cells again provided less than 1% of all
CD45+ cells (Figure 3H). These data demonstrate the absence
of LT-HSCs in primary recipient BM after Fubp1 knockdown.
Intriguingly, multilineage differentiation was not affected (Fig-
ure 3G). Of note, LT-HSCs transduced with Fubp1 shRNA #1,
which displayed less knockdown efficiency, showed a slightly
higher chimerism than Fubp1 shRNA #2-transduced LT-HSCs
in both the primary and secondary transplantations.
Because the amount of transduced Fubp1 knockdown donor
cells was already low 8 weeks after primary transplantation, we
were limited to a small number of recipient mice in our secondary
transplantation experiments. Consequently, the injection of the
same small number of scrambled shRNA-transduced donor cells
resulted in a rather low engraftment. Nevertheless, our results
strongly suggest that the observed phenotype is due to the influ-
ence of reduced FUBP1 levels on adult LT-HSC self-renewal, a
discovery that will be further analyzed in future serial blood
reconstitution assays.
The analysis of lineage contribution in the periphery of trans-
planted mice (Figures 3D and 3G) and the results from the col-
ony-formation assays with total Fubp1null/null FL cells (Figure 1D)
and prospectively isolated multipotent and committed progeni-
tor populations (Figure S2) suggest that FUBP1 is not required
for the lineage choice and differentiation of hematopoietic line-
ages. However, we did not test the full functionality of the mature
blood cells lacking FUBP1. This observation correlates with
the results of ex vivo colony-formation assays performed using
adult Fubp1-knockdown HSPCs. All types of colonies were
formed in the absence of FUBP1 expression (data not shown),
which argues that FUBP1 is not required for such colony gener-
ation. In summary, it appears that FUBP1 fulfills a crucial stem
cell-intrinsic function, enabling self-renewal in both fetal and
adult LT-HSCs.
The Absence of FUBP1 Alters Target Gene Expression,
Decelerates Proliferation, and Increases Cell Death
Rates in LT-HSCs
Given that FUBP1 functions as a transcriptional regulator, we
sought to identify genes involved in LT-HSC self-renewal that
are controlled by FUBP1. Using qPCR, we assessed the ex-
pression levels of 34 candidate genes in adult LT-HSCs after
transduction with Fubp1 shRNA #2 or scrambled shRNA. The
selected genes were either involved in the regulation of HSC
self-renewal or represented known FUBP1 target genes (Fig-
ure 4A; Table S2). Several genes implicated in the regulation of
HSC self-renewal, apoptosis, and proliferation were differentially
expressed, including HoxA10, p21, and Noxa. The cell-cycle in-
hibitor gene p21 and the pro-apoptotic Bcl-2 gene family mem-
ber Noxa have been previously identified as relevant FUBP1
target genes in HCCs (Rabenhorst et al., 2009), and their upregu-
lation (3-fold for p21 and 2.4-fold for Noxa mRNA) suggests
increased cell death and decelerated proliferation, thereby pre-
venting robust LT-HSC self-renewal and expansion. Indeed,
cell culture experiments confirmed that LT-HSCs depleted of
FUBP1 barely expanded during 7 days of culture, while control
cell numbers increased exponentially (Figure 4B). A cell-cycle
Figure 2. FUBP1-Deficient FLs Contain Less Functional LT-HSCs
with Diminished Self-Renewal Capacity
(A) Experimental scheme.
(B–E) Multi-lineage donor cell reconstitution (CD45.2+) of lethally irradiated
recipient mice (seven per group; one experiment) after competitive trans-
plantation of FUBP1-deficient E15.5 FL cells (GT 1) compared with WT cells,
measured in PB (B and C) and BM (D and E) by flow cytometry (n = 3mice for D
and E).
(F and G) Fubp1null/nullCD45.2+ lin c-Kit+ cells isolated from the BM of primary
recipients failed to engraft upon secondary transplantation in PB (F, n = 5) and
BM (G, n = 3). Test for statistical significance: Mann-Whitney; bar charts
represent the mean and SD.
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analysis of ex vivo cultured FUBP1-deficient LT-HSCs showed a
significant decrease of cells in the S phase of the cell cycle and
an increase of cells in theG1 phase (Figures 4C and S4A), a result
that verifies the reduced proliferation potential of FUBP1-defi-
cient LT-HSCs.
Dysfunctional self-renewal of LT-HSCs leads to exhaustion of
the hematopoietic system. To assess FUBP1-deficient LT-HSC
impairment in self-renewal and long-term blood reconstitution
and to validate the proposed functional changes caused by
the absence of FUBP1, namely decreased proliferation and
increased incidence of cell death, we continuously observed in-
dividual LT-HSCs and their progeny via videomicroscopy-based
cell tracking (Rieger et al., 2009; Thalheimer et al., 2014). Adult
LT-HSCs were lentivirally transduced with Fubp1 shRNA #2 or
scrambled shRNA and immediately subjected to time-lapse
microscopy. The cells were monitored for 8 days to measure
cell-cycle length and cell death events in each generation at
single cell resolution (Figure 4D; Movies S1 and S2). The trans-
duction of individual cells was determined by monitoring the
co-expression of the fluorescent reporter protein Venus. Fubp1
knockdown drastically increased the adult LT-HSC death rate
in subsequent generations (generations 2 to 5; Figure 4E).
Furthermore, the average time span between cell divisions of
FUBP1-depleted LT-HSCs was significantly larger than in con-
trol cells of the same generation (Figure 4F). Overall, increased
cell death rates and prolonged generation times resulted in the
reduced expansion of FUBP1-deficient LT-HSCs in culture and
most likely in the markedly reduced self-renewal capacity of
LT-HSCs lacking functional FUBP1.
The minimal prerequisites for self-renewal of LT-HSCs are
cell survival and division. In this study, we found that the sin-
gle-stranded DNA-binding protein FUBP1 is absolutely essential
for fetal and adult LT-HSC self-renewal, which acts by controlling
the transcriptional network that governs survival and prolifera-
tion of LT-HSCs (see working model presented in Figure S4B).
Interestingly, all committed progenitors and mature blood
cells are generated in the absence of FUBP1 (although we did
not investigate the functionality of the differentiated cells),
which suggests that FUBP1 plays a specific role in the hemato-
poietic cell type with extensive self-renewal ability, namely
Figure 3. FUBP1 Is Intrinsically Required for Adult HSC Self-Renewal
(A) Experimental scheme.
(B) Western blot of lysates from MPPs lentivirally transduced with shRNAs.
(C and D) Multi-lineage donor cell reconstitution (CD45.2+ Venus+) of lethally irradiated recipient mice (eight per group; one experiment) after competitive
transplantation of LT-HSCs transduced with Fubp1 or scrambled shRNAs.
(E) BM analysis of recipient mice 8 (n = 4) and 27 (n = 3) weeks post-transplantation.
(F–H) Quantification of CD45.2+ Venus+ cells in the PB (F, scrambled and Fubp1 shRNA #1: n = 5, Fubp1 shRNA #2: n = 6) and BM (H, scrambled shRNA: n = 4,
Fubp1 shRNA #1: n = 5, Fubp1 shRNA #2: n = 6) of secondary recipient mice. Test for statistical significance: Mann-Whitney; bar charts represent the mean
and SD.
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LT-HSCs. However, Fubp1 mRNA expression within HSPCs is
not restricted to LT-HSCs (Figure S4C).
Our LT-HSC expression analysis reveals that several genes
implicated in LT-HSC self-renewal, including c-myc, p21, and
Noxa, are deregulated in the absence of FUBP1 (Figure 4A).
c-myc was the first identified direct FUBP1 target gene (Duncan
et al., 1994), and we confirmed significant downregulation of
c-myc mRNA expression in adult Fubp1 knockdown LT-HSCs.
c-myc plays an important role in hematopoiesis as well as
HSC self-renewal and differentiation (Laurenti et al., 2009). How-
ever, the reported accumulation of non-functional LT-HSCs in
tissue-specific c-myc-knockout embryos (Dubois et al., 2008)
Figure 4. The Transcriptional Regulator
FUBP1 Promotes Proliferation and Survival
of LT-HSCs, Thereby Enabling LT-HSC
Self-Renewal
(A) qPCR of FACS-isolated adult LT-HSCs trans-
duced with scrambled or Fubp1 shRNA #2. Rela-
tive expression levels (log2; fold change between
Fubp1 shRNA #2- and scrambled shRNA-trans-
duced HSCs) were normalized to the geometric
mean of six housekeeping genes (Hprt, b-Act,
Pum1, Gusb, B2m, and Gapdh). Data are pre-
sented as the mean and SD and with a heatmap
(four independent experiments).
(B) Culture of lentivirally transduced LT-HSCs,
three independent experiments.
(C) Cell-cycle analysis of ex vivo cultured lenti-
virally transduced LT-HSCs, three independent
experiments.
(D) Representative pedigrees of two tracked LT-
HSCs that had been transduced with scrambled
shRNA (left) or Fubp1 shRNA #2 (right).
(E and F) Cell tracking revealed increased cell
death rates (E) and prolonged generation times
(F) upon Fubp1 knockdown (three independent
experiments). Numbers of tracked cells for each
generation: 173–639 scrambled shRNA-trans-
duced cells and 189–268 Fubp1 shRNA#2-trans-
duced cells. Test for statistical significance:
unpaired Student’s t test. Data are represented as
the mean and SD or as boxes (25%–75%) and
whiskers with 2.5–97.5 percentile.
and adult mice (Wilson et al., 2004) con-
trasts with our observations in FUBP1-
deficient embryos and mice transplanted
with adult Fubp1-knockdown HSCs,
challenging c-myc as the most relevant
target gene to explain the defective self-
renewal of FUBP1-deficient HSCs. With
p21 and Noxa, we identified two genes
controlling cell-cycle progression and
cell death that are suppressed by
FUBP1 in LT-HSCs. p21 binds to cyclin-
dependent kinase (CDK)/cyclin com-
plexes, thereby inhibiting CDK activity
and cell-cycle progression (Warfel and
El-Deiry, 2013). NOXA belongs to the
pro-apoptotic group of BH3 domain-
only proteins, a subclass of the BCL-2 family (Ploner et al.,
2008). In previous studies, we have demonstrated that both
genes are suppressed upon frequent overexpression of FUBP1
in HCCs (Rabenhorst et al., 2009). Furthermore, downregulation
of FUBP1 in HCC cell lines increased apoptosis sensitivity
and slowed cell-cycle progression, thereby leading to reduced
tumorigenicity. We observed a similar pro-apoptotic and anti-
proliferative phenotype in LT-HSCs lacking FUBP1, which
strongly indicates that the suppression of both genes to levels
below a certain threshold is instrumental for HSC self-renewal
and expansion. Conversely, overexpression of both genes was
shown to interfere with normal LT-HSC function: homozygous
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Ptpn11/ mice deficient in Src homology 2 domain-containing
phosphatase 2 (SHP2) showed a rapid loss of LT-HSCs due to
apoptosis concomitant with increased NOXA expression (Chan
et al., 2011), and the accumulation of p21 and p27 in GATA-2-
overexpressing HSPCs suppressed cytokine-dependent growth
(Ezoe et al., 2002). Our results show that self-renewal of HSCs
not only requires the activation, but also the repression of certain
gene programs.
FUBP1 is absolutely essential for LT-HSC self-renewal in em-
bryos and adult organisms. This contrasts with other factors that
have been shown to be specifically important for either fetal or
adult HSC self-renewal, such as TAL1 (Mikkola et al., 2003),
SOX17 (Kim et al., 2007), or RUNX1 (Ichikawa et al., 2004).
Indeed, fundamental differences in the molecular state of fetal
and adult LT-HSCs as well as the regulatory transcriptional net-
works that govern LT-HSC self-renewal and maintain their stem-
ness and repopulating capacity have been described (Wilkinson
and Go¨ttgens, 2013).
The observation that FUBP1 plays a central role in fetal
and adult LT-HSC self-renewal adds another level of complexity
to the regulation of transcription by DNA structure. The accessi-
bility of the melted single-strand DNA element FUSE is the
first prerequisite for FUBP1 to become involved in gene re-
gulation upon binding to FUSE sites in the vicinity of gene pro-
moters. Therefore, FUBP1 represents the prototype of molecular
switches that translate structural DNA information into the acti-
vation or inhibition of promoters regulating LT-HSC self-renewal.
The integration of FUBP1 expression and function and its regu-
lation by intrinsic and extrinsic factors warrants future investiga-
tions to further our understanding of self-renewal mechanisms
for the longstanding goal of therapeutic LT-HSC expansion. It
will be intriguing to find out whether FUBP1 fulfills a similar func-
tion for the self-renewal of other somatic or embryonic stem
cells. Furthermore, the oncogenic potential of FUBP1 overex-
pression has already been demonstrated in human HCCs
(Malz et al., 2009; Rabenhorst et al., 2009) and other tumor en-
tities (data not shown), and FUBP1 mRNA levels were shown
significantly elevated in leukemia stem cell-enriched cell popula-
tions (Eppert et al., 2011). Thus, it will be of great interest to
understand the role that FUBP1 plays in tumor-initiating cells
(cancer stem cells).
EXPERIMENTAL PROCEDURES
Mouse Lines
Two heterozygous Fubp1null/+ gene trapmouse strains were established via in-
jection of the ES cell clones A033A08 (GT 1, gene trap integration into Fubp1
intron 18; oligonucleotides used for genotyping were 50-CTGGGTTCAAATCC
CACTAC-30 [primer 50 ], 50-TACCTAGCTCACCACTCTTC-30 [primer wt-30] and
50-ACGGGTTCTTCTGTTAGTCC-30 [primer trap-30]) and 5SE293C09 (GT 2,
gene trap integration into Fubp1 intron 1; oligonucleotides used for genotyping
were 50-CCTGGCAGGTCTCTTGAGTT-30 [primer 50-2], 50-CCAAAGGGTCC
TACATGGAA-30 [primer wt-30-2] and 50-AGTGATTGACTACCCGTCAGC-30
[primer trap-30-2]) obtained from the International Gene Trap Consortium
(IGTC; http://www.genetrap.org/index.html). The GT 1 strain expresses a
non-functional fusion protein consisting of aa 1-589 of FUBP1, the b-galacto-
sidase (b-Gal) and the aminoglycoside 30-phosphotransferase (APT) protein
(Figure 1B, left). The GT 2 strain expressed no FUBP1 protein sequence
(Figure 1B, right). The mutant animals were bred into the C57Bl/6J strain
(Charles River) before analysis. CD45.1+ B6.SJL mice were purchased from
Jackson Laboratory. All mice were bred and maintained under specific path-
ogen-free conditions in the animal facility at the Georg-Speyer-Haus. Experi-
ments were performed in accordance with German animal welfare legislation
and were approved by the relevant authorities (Regierungspra¨sidium
Darmstadt).
Isolation of BMCs and Lineage Depletion
BMCs were isolated from the femurs and the tibias by flushing the bones
using a syringe with a blunt needle or by crushing the femurs, tibias, and ster-
nums in sterile PBS/2% fetal bovine serum (FBS). After flushing, mononuclear
cells from murine BM were isolated via density gradient centrifugation using
Histopaque 1083 (Sigma-Aldrich) according to the manufacturer’s instruc-
tions. Lineage depletion of FL cells and BMCs was performed using the
EasySep Kit (Stem Cell Technologies) according to the manufacturer’s
protocol. Biotinylated antibodies against B220 (RA3-6B2), CD3 (145-2C11),
CD19 (eBio1D3), CD41 (eBioMWReg30), Gr-1 (RB6-8C5), Mac-1 (M1/70),
and Ter119 (TER-119) were used to isolate lineage-depleted cells. For FL
cell lineage depletion, anti-Mac-1 (Morrison et al., 1995), and anti-CD41 anti-
bodies were excluded from the antibody cocktail (see Table S1 for detailed
antibody information).
Staining and Sorting of Fetal and Adult HSPC Populations
Fetal and adult LT-HSCs were isolated from FLs and adult BM, respectively.
The cells were quantified using trypan blue and a hemocytometer, and the
cells were incubated with the appropriate antibodies in PBS (pH 7.4) contain-
ing 10% FBS, 1 mM EDTA, and 0.1% sodium azide. FL HSPC staining was
performed using the following antibodies against Sca-1 (D7), CD117 (2B8),
CD48 (HM48.1), CD150 (TC15-12F12.2), and Mac-1 (M1/70). For BM HSPCs,
antibodies against Sca-1 (D7), CD117 (2B8), CD48 (HM48.1), CD150 (TC15-
12F12.2), and CD34 (RAM34) were used. Streptavidin was added for detection
of remaining lineage+ cells (lineage biotin cocktail; see above). For progenitor
analysis of transplanted BM, anti-CD45.1 (A20) and anti-CD45.2 (104) anti-
bodies were included in addition to the above mentioned antibodies. Flow
cytometric analysis was performed using a FACSCalibur or a FACSCanto II
(Becton Dickinson), and cells were sorted using a FACSAria I (Becton Dickin-
son). Gating of BMHSPC populations was done as shown in (Thalheimer et al.,
2014). Living cells after sorting were counted by trypan blue exclusion. Data
analysis was carried out using FACS Diva, CellQuest (Becton Dickinson),
and FlowJo (Tree Star) software.
Flow Cytometry for Donor Cell Engraftment in PB
Whole mouse blood samples (50 ml) were harvested, and erythrocytes were
lysed in ACK lysis buffer (GIBCO Life Technologies). After washing, the cells
were used for antibody staining (Gr-1 [RB6-8C5], Mac-1 [M1/70], CD3 [145-
2C11], B220 [RA3-6B2], CD45.1 [A20], and CD45.2 [104]) and flow cytometric
analysis.
Competitive Transplantation
CD45.1+ B6.SJL recipient mice were lethally irradiated with 9.5 Gy (Biobeam
2000). CD45.2+ FL cells or fluorescence-activated cell sorting (FACS)-sorted
adult HSCs (1-day post-transduction) resuspended in PBS were injected
into the tail vein together with 2 3 105 non-fractionated BMCs isolated from
CD45.1+ B6.SJL mice.
Quantitative Real-Time PCR
Lentivirally transduced Venus+ CD48 HSCs were sorted directly into lysis
buffer 2 days after transduction of LT-HSCs. cDNA synthesis, cDNA pre-
amplification, and TaqMan qPCR assays were then carried out using a Roche
LightCycler480 PCR system and the TaqMan PreAmp Cells-to-CT Kit (Life
Technologies) according to the manufacturer’s instructions. TaqMan Gene
Expression Assays were purchased from Life Technologies (see Table S2).
Data analysis was performed using the DDCT-method (Schefe et al., 2006).
The geometric mean of six housekeeping genes (Hprt, b-Act, Pum1, Gusb,
B2m, and Gapdh) was used to normalize the data. The log2 fold change of
all genes of interest was calculated to compare Fubp1 shRNA #2-transduced
knockdown and scrambled shRNA-transduced control cells.
Cell Reports 11, 1847–1855, June 30, 2015 ª2015 The Authors 1853
Colony-Forming Unit Assay
For colony-formation assays, 53 103 total FL cells were mixed withMethoCult
methylcellulose medium (M3434, Stem Cell Technologies) and then plated
according to the manufacturer’ s instructions. The colonies were scored via
microscopy at day 11.
Time-Lapse Imaging
FACS-sorted LT-HSCs (30–50 cells/per well) were cultured in 24-well plates
(SFEM medium, 100 ng/ml stem cell factor [SCF] and thrombopoietin [TPO])
equipped with silicon culture inserts (IBIDI) and immediately transduced with
lentiviral particles (MOI 300). The plates were gas-tight sealed with adhesive
tape after 5% CO2 saturation. Microscopy was performed using a Cell
Observer (Zeiss) at 37C. Phase contrast images were acquired every
2–3 min using a 103 phase contrast objective (Zeiss) and an AxioCamHRm
camera (at 1,388 3 1,040 pixel resolution) with a self-written VBA module
remote controlling the Zeiss AxioVision 4.8 software. Fluorescence was de-
tected every 1–2 hr using HXP illumination (Osram) and a filter set for EYFP
(F46-003, AHF Analysetechnik).
Cell Tracking
Cell tracking was performed as previously described (Rieger et al., 2009; Thal-
heimer et al., 2014) until the fate of all progeny in the fifth generation was deter-
mined or until cells had died.
Ex Vivo Culture of LT-HSCs
FACS-sorted LT-HSCs (100 cells per well) were cultured in 96-well plates after
lentiviral transduction (MOI = 300) in SFEM medium (StemCell Technologies)
supplemented with either SCF or SCF and TPO (100 ng/ml, Peprotech) at
5% CO2 and 37
C. On days 3, 5 and 7, cells were counted and analyzed via
flow cytometry for Venus fluorescence.
BrdU Cell Proliferation Assay
For cell-cycle analysis, the BrdU Flow Kit (BD Pharmingen) was used
according to the manufacturer’s instructions. LT-HSCs were transduced as
described above and cultured in SFEMmedium (Stem Cell Technologies) sup-
plemented with 100 ng/ml SCF and TPO (Peprotech). On day 3 after transduc-
tion, LT-HSCs were pulsed with BrdU for 45 min. 7-AAD was used to quantify
total DNA amounts. Flow cytometric analysis of Venus+ cells was performed
using a LSR Fortessa (Becton Dickinson).
Statistical Analyses
The statistical analyses indicated in the figure legends were performed with
Prism 5 for Mac OS X, GraphPad Prism Software; *p < 0.05, **p < 0.01,
***p < 0.001.
Additional information about experimental procedures is presented in the
Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, two tables, and two movies and can be found with this article on-
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